<div id="readability-page-1"><p>Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 3,520 shares of the stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $40.06, for a total value of $141,011.20. Following the transaction, the chief executive officer owned 46,240 shares of the company's stock, valued at approximately $1,852,374.40. The trade was a 7.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.</p><p>Jack Bendheim also recently made the following trade(s): </p><ul><li>On Tuesday, December 9th, Jack Bendheim sold 1,288 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.19, for a total transaction of $51,764.72. </li><li>On Wednesday, December 3rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.77, for a total transaction of $143,510.40. </li><li>On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.93, for a total transaction of $309,267.20. </li><li>On Wednesday, November 26th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.02, for a total transaction of $232,425.60. </li><li>On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.56, for a total value of $235,276.80. </li><li>On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.47, for a total value of $391,380.47. </li><li>On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.23, for a total value of $974,073.28. </li><li>On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87. </li><li>On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $42.86, for a total value of $150,867.20. </li><li>On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.10, for a total value of $151,712.00. </li></ul><div><p><span></span><span>Get <strong>Phibro Animal Health</strong> alerts:</span></p></div><h2>Phibro Animal Health Stock Up 4.3%</h2><p>Shares of NASDAQ:PAHC traded up $1.63 during midday trading on Wednesday, hitting $39.91. The stock had a trading volume of 282,957 shares, compared to its average volume of 280,482. The company has a market cap of $1.62 billion, a P/E ratio of 24.04, a PEG ratio of 1.14 and a beta of 0.77. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $46.42. The business's 50-day simple moving average is $41.18 and its 200-day simple moving average is $34.31. The company has a quick ratio of 1.35, a current ratio of 3.09 and a debt-to-equity ratio of 2.32. </p><p>Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.58 by $0.15. The firm had revenue of $363.89 million during the quarter, compared to analysts' expectations of $345.44 million. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS.  On average, sell-side analysts forecast that  Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year. </p><h2>Phibro Animal Health Announces Dividend</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health's payout ratio is currently 28.92%. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research analysts recently weighed in on the company. JPMorgan Chase &amp; Co. boosted their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an &#34;overweight&#34; rating in a report on Friday, November 7th. Bank of America upped their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an &#34;underperform&#34; rating in a report on Friday, August 29th. Weiss Ratings  restated a &#34;buy (b-)&#34; rating on shares of Phibro Animal Health in a research note on Monday. Zacks Research cut shares of Phibro Animal Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Monday, November 10th. Finally, Morgan Stanley  set a $34.00 price objective on Phibro Animal Health in a report on Thursday, August 28th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned  a Sell rating to the company. According to data from MarketBeat, Phibro Animal Health currently has a consensus rating of &#34;Hold&#34; and an average target price of $31.40.</p><p><b>Get Our Latest Stock Analysis on PAHC</b></p><h2>Institutional Inflows and Outflows</h2><p>A number of hedge funds and other institutional investors have recently bought and sold shares of PAHC. Cetera Investment Advisers grew its stake in  Phibro Animal Health by 18.9% during the first quarter. Cetera Investment Advisers now owns 11,550 shares of the company's stock worth $247,000 after buying an additional 1,840 shares in the last quarter.  LPL Financial LLC boosted its position in shares of  Phibro Animal Health by 46.8% during the 1st quarter. LPL Financial LLC now owns 128,335 shares of the company's stock worth $2,741,000 after acquiring an additional 40,889 shares in the last quarter.  Vanguard Group Inc. increased its stake in  Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after acquiring an additional 6,784 shares during the last quarter.  National Bank of Canada FI acquired a new position in  Phibro Animal Health during the first quarter valued at approximately $30,000.  Finally, Invesco Ltd. lifted its stake in  Phibro Animal Health by 92.3% during the first quarter. Invesco Ltd. now owns 387,739 shares of the company's stock worth $8,282,000 after purchasing an additional 186,087 shares during the last quarter. Institutional investors and hedge funds own  99.34% of the company's stock. </p><h2>Phibro Animal Health Company Profile</h2> (Get Free Report)<p>Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.</p><h2>See Also</h2><ul><li>Five stocks we like better than Phibro Animal Health</li><li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025 </li><li>The Top 3 Investment Themes That Will Dominate 2026</li><li>What Makes a Stock a Good Dividend Stock?</li><li>Vertical’s Valo Launch: A Commercial Leap Disguised as a Dip</li><li>Canadian Penny Stocks: Can They Make You Rich? </li><li> Dividend Stocks for 2026: Where to Invest as the Market Cools</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFIQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Phibro Animal Health Right Now?</h2><p>Before you consider Phibro Animal Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.</p><p>While Phibro Animal Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

PAHC

<p>Phibro Animal Health CEO Jack Bendheim sold 3,520 shares, reducing his ownership by 7.07%. The shares were sold at $40.06 each, totaling $141,011.20. Post-sale, Bendheim owns 46,240 shares valued at $1,852,374.40. This transaction was disclosed in an SEC filing. Additionally, Bendheim has made several other stock sales recently. Phibro's stock rose 4.3% to $39.91, with a market cap of $1.62 billion. The company announced a quarterly dividend of $0.12 per share, with a payout ratio of 28.92%. Analysts have adjusted their target prices for the company.</p>

Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 3,520 Shares